GlassScriptPhysician profile
Amanda Gandert
NPI 1033557236
$4,394.63
in general payments reported to CMS, 2019-2025
36 companies · $919 in 2025
The $919 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $687 · 2022: $908 · 2023: $821 · 2024: $1,060 · 2025: $919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,800.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $987.69 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $518.21 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $297.37 | 2021-2025 | Mounjaro, Jardiance, Emgality |
| Alexion Pharmaceuticals, INC. | $227.20 | 2022-2025 | Strensiq |
| Janssen Pharmaceuticals, INC | $226.41 | 2021-2025 | Spravato |
| Novo Nordisk INC | $195.16 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $175.40 | 2021-2025 | |
| Glaxosmithkline, LLC. | $167.39 | 2021-2025 | Bexsero, Arexvy, Shingrix |
| Novartis Pharmaceuticals Corporation | $165.59 | 2022-2024 | |
| Astellas Pharma US INC | $131.23 | 2021-2025 | Veozah, Myrbetriq |
| Abbott Laboratories | $116.84 | 2021-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $105.78 | 2022-2025 | |
| Exact Sciences Corporation | $89.47 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $89.42 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $86.82 | 2022-2023 | Rexulti |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Gandert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.